Oncology Nursing News Top Stories: October 2020

Article

Each month, we take a look back at the most popular Oncology Nursing News® stories. Here are the top 5 stories from October 2020.

Each month, we take a look back at the most popular Oncology Nursing News® stories. Here are the top 5 stories from October 2020.

5. Nivatrotamab Granted Orphan Drug Status for Pediatric Neuroblastoma

The FDA granted an orphan drug designation and rare pediatric disease designation to the bispecific antibody nivatrotamab for the treatment of patients with neuroblastoma, according to an announcement from Y-mAbs Therapeutics, Inc.

4. We Honor Oncology Nurses for Their Dedication

This letter from our Chairman and Founder, Mike Hennessy, Sr., about the recent Extraordinary Healer and Finest Hour awards explores why nurses should be celebrated year-round for their dedication to patients with cancer.

3. Frontline Treatment Decisions Are Crucial in Myeloma

In recent years, 5-year survival rates have increased for patients with myeloma. However, the majority of patients will still relapse after their treatment — some faster than others – highlighting the importance of establishing the longest possible remission the first time around.

2. A Smiling Nurse Makes All the Difference in Pediatric Oncology

Being hospitalized for cancer can be a frightening experience for a child, but here, we take a look at how a friendly and approachable nurse can make all the difference.

1. Chemo Cheat Sheets Help Nurses During Drug Delivery

In this episode of The Vitals, Oncology Nursing News’ podcast, we spoke with Kellie Zeichner, RN, BSN, OCN, an oncology nurse at the Rutgers Cancer Institute of NJ, about how she worked with an interdisciplinary team to create reference sheets containing key information about oncology drugs.

Thanks for reading!

Recent Videos
Ann H. Partridge, MD, MPH, in an interview with Oncology Nursing News at 2024 ESMO Congress.
Elizabeth Burton in an interview with Oncology Nursing News
2 KOLs are featured in this series.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
© 2024 MJH Life Sciences

All rights reserved.